Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,712 | 4,584 | 5,881 | 4,606 | 5,915 |
| TOTAL | $28,845 | $4,803 | $6,181 | $5,014 | $6,079 |
| Non-Current Assets | |||||
| Investments And Advances | 241 | 422 | 490 | 643 | 720 |
| Intangibles | 3 | 3 | 3 | 3 | 3 |
| TOTAL | $244 | $424 | $493 | $646 | $723 |
| Total Assets | $29,089 | $5,227 | $6,674 | $5,660 | $6,802 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,624 | 574 | 655 | 556 | 671 |
| Accrued Expenses | 2,497 | 937 | 742 | 599 | 540 |
| TOTAL | $5,121 | $1,510 | $1,397 | $1,155 | $1,211 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 62,345 | 0 | 0 | 0 | 0 |
| TOTAL | $62,345 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $67,466 | $1,510 | $1,397 | $1,155 | $1,211 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,626 | 2,144 | 1,428 | 960 | 873 |
| Common Shares | 3 | 2 | 1 | 24 | 22 |
| Retained earnings | -143,984 | -91,995 | -89,972 | -87,976 | -86,183 |
| TOTAL | $-38,377 | $3,717 | $5,277 | $4,505 | $5,591 |
| Total Liabilities And Equity | $29,089 | $5,227 | $6,674 | $5,660 | $6,802 |